- Home
- HRTX vs RM Comparison
HRTX vs RM Comparison
Compare HRTX & RM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRTX
- RM
- Stock Information
- Founded
- HRTX 1983
- RM 1987
- Country
- HRTX United States
- RM United States
- Employees
- HRTX N/A
- RM N/A
- Industry
- HRTX Biotechnology: Pharmaceutical Preparations
- RM Finance: Consumer Services
- Sector
- HRTX Health Care
- RM Finance
- Exchange
- HRTX Nasdaq
- RM Nasdaq
- Market Cap
- HRTX 276.1M
- RM 314.9M
- IPO Year
- HRTX 1987
- RM 2012
- Fundamental
- Price
- HRTX $1.33
- RM $37.64
- Analyst Decision
- HRTX Strong Buy
- RM Hold
- Analyst Count
- HRTX 2
- RM 2
- Target Price
- HRTX $4.50
- RM $30.00
- AVG Volume (30 Days)
- HRTX 2.2M
- RM 44.4K
- Earning Date
- HRTX 08-08-2025
- RM 07-30-2025
- Dividend Yield
- HRTX N/A
- RM 3.19%
- EPS Growth
- HRTX N/A
- RM 35.30
- EPS
- HRTX N/A
- RM 3.47
- Revenue
- HRTX $149,694,000.00
- RM $591,436,000.00
- Revenue This Year
- HRTX $12.08
- RM $13.10
- Revenue Next Year
- HRTX $12.57
- RM $9.35
- P/E Ratio
- HRTX N/A
- RM $10.84
- Revenue Growth
- HRTX 9.78
- RM 7.19
- 52 Week Low
- HRTX $1.04
- RM $25.41
- 52 Week High
- HRTX $2.68
- RM $38.61
- Technical
- Relative Strength Index (RSI)
- HRTX 28.25
- RM 71.66
- Support Level
- HRTX $1.31
- RM $31.29
- Resistance Level
- HRTX $1.47
- RM $34.87
- Average True Range (ATR)
- HRTX 0.11
- RM 1.16
- MACD
- HRTX -0.04
- RM 0.42
- Stochastic Oscillator
- HRTX 19.72
- RM 88.07
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
About RM Regional Management Corp.
Regional Management Corp is a diversified consumer finance company that provides installment loan products to customers with limited access to consumer credit from banks, thrifts, credit card companies, and other lenders. It is engaged in consumer finance. The company has the core products which are small and large installment loans. The company also offers optional payment and collateral protection insurance. The company's principal source of revenue is interest and fee income on outstanding loans.